EI
EW icon

Ethic Inc’s Edwards Lifesciences EW Stock Holding History

Ethic Inc’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.56M Buy
61,470
+2,881
+5% +$241K 0.07% 278
2026
Q1 		$4.69M Buy
58,589
+9,610
+20% +$792K 0.07% 274
2025
Q4 		$4.18M Buy
48,979
+4,403
+10% +$361K 0.06% 298
2025
Q3 		$3.47M Sell
44,576
-10,056
-18% -$786K 0.06% 329
2025
Q2 		$4.27M Sell
54,632
-1,536
-3% -$115K 0.08% 268
2025
Q1 		$4.04M Buy
56,168
+15,775
+39% +$1.13M 0.08% 253
2024
Q4 		$2.99M Sell
40,393
-6,231
-13% -$436K 0.06% 320
2024
Q3 		$4.46M Sell
46,624
-5,931
-11% -$431K 0.11% 213
2024
Q2 		$4.85M Buy
52,555
+5,931
+13% +$525K 0.11% 192
2024
Q1 		$4.46M Buy
46,624
+8,329
+22% +$700K 0.11% 213
2023
Q4 		$2.92M Buy
38,295
+486
+1% +$33.8K 0.09% 276
2023
Q3 		$2.62M Buy
37,809
+2,266
+6% +$182K 0.09% 261
2023
Q2 		$3.35M Buy
+35,543
New +$3.09M 0.12% 204
2023
Q1 		– Sell
-35,065
Closed -$2.62M – 978
2022
Q4 		$2.62M Sell
35,065
-13,035
-27% -$1M 0.14% 189
2022
Q3 		$3.98M Sell
48,100
-2,856
-6% -$275K 0.27% 91
2022
Q2 		$4.84M Buy
50,956
+4,641
+10% +$480K 0.34% 65
2022
Q1 		$5.45M Buy
46,315
+6,650
+17% +$746K 0.38% 52
2021
Q4 		$5.14M Buy
39,665
+5,332
+16% +$622K 0.4% 53
2021
Q3 		$3.89M Buy
34,333
+3,623
+12% +$414K 0.4% 53
2021
Q2 		$3.18M Buy
30,710
+7,084
+30% +$668K 0.39% 53
2021
Q1 		$1.98M Buy
23,626
+6,645
+39% +$562K 0.35% 61
2020
Q4 		$1.55M Buy
16,981
+5,681
+50% +$471K 0.41% 48
2020
Q3 		$902K Buy
11,300
+3,014
+36% +$235K 0.34% 69
2020
Q2 		$573K Buy
8,286
+1,947
+31% +$138K 0.33% 78
2020
Q1 		$399K Buy
6,339
+339
+6% +$24.4K 0.33% 97
2019
Q4 		$467K Buy
+6,000
New +$469K 0.34% 98

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
TIM
Triodos Investment Management Driebergen-Rijsenburg, Netherlands $1.64B AUM 37.98% 1-Year Est. Return

Ethic Inc's EW Position: Q2 2026 in Review

Ethic Inc increased its Edwards Lifesciences (EW) stake by 4.9% in Q2 2026, buying an estimated $241K and bringing the position to 61,470 shares worth $5.56M. The position accounts for 0.07% of the portfolio, ranked #278.

Ethic Inc first reported a position in EW in Q4 2019 and has held it in 26 quarters since. 501 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Ethic Inc held 61,470 shares of Edwards Lifesciences worth $5.56M as of Q2 2026.
  • Ethic Inc bought 2,881 Edwards Lifesciences shares in Q2 2026, an estimated $241K.
  • Edwards Lifesciences made up 0.07% of Ethic Inc's portfolio in Q2 2026, its #278 holding.
  • Ethic Inc first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 26 quarters since.
  • 501 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.